Sign in
4

Changes in Ownership

Propanc Biopharma, Inc. Filed Acc 0000891839-16-000266

CEO, CFO, Secretary, Treasurer acquired 33,259,350 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nathanielsz James Andrew CEO, CFO, Secretary, Treasurer 2015-02-04 Other acquisition +33,259,350 42,711,111 I
Derivatives
Nathanielsz James Andrew CEO, CFO, Secretary, Treasurer 2016-04-14 Grant or award · Stock Option (Right to Buy) +71,500,000 71,500,000 D
Loading xslF345X03/edgar.xml…